[go: up one dir, main page]

CN102660524A - Sequence of high-expression high-specific-activity H1 Collagenase mutant, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain - Google Patents

Sequence of high-expression high-specific-activity H1 Collagenase mutant, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain Download PDF

Info

Publication number
CN102660524A
CN102660524A CN201210141391XA CN201210141391A CN102660524A CN 102660524 A CN102660524 A CN 102660524A CN 201210141391X A CN201210141391X A CN 201210141391XA CN 201210141391 A CN201210141391 A CN 201210141391A CN 102660524 A CN102660524 A CN 102660524A
Authority
CN
China
Prior art keywords
collagenase
torsalo
mutants
expression
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210141391XA
Other languages
Chinese (zh)
Other versions
CN102660524B (en
Inventor
陈海宁
程云开
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Huayan Collagen Technology Co.,Ltd.
Original Assignee
HAINAN HUAYAN BIOTECH CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAINAN HUAYAN BIOTECH CO Ltd filed Critical HAINAN HUAYAN BIOTECH CO Ltd
Priority to CN 201210141391 priority Critical patent/CN102660524B/en
Publication of CN102660524A publication Critical patent/CN102660524A/en
Application granted granted Critical
Publication of CN102660524B publication Critical patent/CN102660524B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明涉及皮蝇胶原酶(HlCollagenase)突变体的序列及其分泌表达的酵母菌株HlCollagenase-m/pGAPZα-A/GS115构建的关键技术、构建结果及利用它来生产高活性皮蝇胶原酶的纯化方法。本发明采用基因工程表达的方法生产高活性的皮蝇胶原酶突变体,比活性达到1320国际单位/毫克,表达量达到241毫克/升蛋白,通过纯化可获得纯度达95%以上的目标蛋白皮蝇胶原酶,为皮蝇胶原酶今后的推广使用奠定良好基础。The present invention relates to the sequence of the mutant HlCollagenase and the key technology for the construction of the secreted and expressed yeast strain HlCollagenase-m/pGAPZα-A/GS115, the construction results and the purification of HlCollagenase produced by using it method. The present invention adopts the method of genetic engineering expression to produce highly active skin fly collagenase mutant, the specific activity reaches 1320 international units/mg, the expression amount reaches 241 mg/liter protein, and the target protein skin with a purity of more than 95% can be obtained through purification. fly collagenase, laying a good foundation for the promotion and use of skin fly collagenase in the future.

Description

高表达高比活皮蝇胶原酶突变体序列、毕赤酵母表达质粒的构建及菌株筛选和纯化方法High-expression high specific live skin fly collagenase mutant sequence, construction of Pichia pastoris expression plasmid, strain screening and purification method

技术领域technical field

本发明涉及具有高比活皮蝇胶原酶(Hl Collagenase) 序列的确认、该序列毕赤酵母表达载体的构建、分泌表达皮蝇胶原酶的毕赤酵母菌株Hl Collagenase-m/ pGAPZα-A/GS115构建的关键技术、构建结果及利用它来生产高活性皮蝇胶原酶的纯化方法。本发明属于生物技术领域。 The present invention relates to the confirmation of the sequence of collagenase (Hl Collagenase) with a high specific liveness, the construction of the Pichia pastoris expression vector of the sequence, and the Pichia yeast strain H1 Collagenase-m/pGAPZα-A/GS115 secreting and expressing the fly collagenase The key technology of the construction, the result of the construction and the purification method of using it to produce highly active collagenase. The invention belongs to the field of biotechnology.

背景技术Background technique

胶原酶的化学名为胶原蛋白水解酶(Collagenase),它能在生理PH和温度条件下特异性地水解天然胶原蛋白的三维螺旋结构,而不损伤其它蛋白质和组织。来自梭菌的胶原酶,切割胶原蛋白中甘氨酸残基的氨基端肽键。而来自皮蝇(Hypoderma lineatum)幼虫的胶原酶,切割天然胶原蛋白丙氨酸残基的氨基端肽键。目前医疗上广泛使用的胶原酶是从溶组织梭状细胞芽孢杆菌提取制备的,主要水解结缔组织中胶原蛋白成分。而来自皮蝇幼虫的胶原酶,由于幼虫体内含量低,提取工艺复杂,生产成本高,至今无法大量生产,阻碍了皮蝇胶原酶的推广使用。 The chemical name of collagenase is collagenase (Collagenase), which can specifically hydrolyze the three-dimensional helical structure of natural collagen under physiological pH and temperature conditions without damaging other proteins and tissues. Collagenase from Clostridium cleaves amino-terminal peptide bonds of glycine residues in collagen. Collagenase from the larvae of the skin fly (Hypoderma lineatum) cleaves the amino-terminal peptide bond of alanine residues in native collagen. Collagenase widely used in medical treatment is extracted and prepared from Clostridium histolyticum, which mainly hydrolyzes collagen components in connective tissue. However, the collagenase from the larvae of the skin fly cannot be mass-produced so far due to the low content in the body of the larvae, complicated extraction process and high production cost, which hinders the popularization and use of the collagenase from the skin fly.

发明内容Contents of the invention

皮蝇胶原酶是皮蝇一期幼虫可溶性抗原的主要成分,是一种丝氨酸蛋白酶,分子量为25223道尔顿,成熟的皮蝇胶原酶含有230个氨基酸,比其前体少了30个氨基酸,整个氨基酸序列和胰蛋白酶家族的丝氨酸蛋白酶的氨基酸序列具有高度的相似性。其活性功能片段为45~180位氨基酸,底物结合区是174~201位氨基酸;全序列共有6个半胱氨酸(30,46;151,166;176,204位氨基酸),形成3对二硫键。根据对皮蝇胶原酶分子结构及序列的分析,我们设计切除1~27位的氨基酸序列,使功能区域更大范围地暴露,使之能够更好的和反应底物结合,从而提高酶的活性。并将第29位的色氨酸(Trp)突变为异亮氨酸(Ile),以保持分子结构的稳定性; Derma collagenase is the main component of the soluble antigen of the first-stage larva of Derma larvae. It is a serine protease with a molecular weight of 25223 Daltons. The mature Derma collagenase contains 230 amino acids, which is 30 amino acids less than its precursor. The whole amino acid sequence has a high similarity with that of the trypsin family serine proteases. The active functional fragment is 45-180 amino acids, and the substrate-binding region is 174-201 amino acids; the whole sequence has 6 cysteines (30,46; 151,166; 176,204 amino acids), forming 3 pairs of disulfide bonds. According to the analysis of the molecular structure and sequence of the collagenase of the fly, we designed to excise the amino acid sequence of positions 1-27, so that the functional area can be exposed in a wider range, so that it can better bind to the reaction substrate, thereby improving the activity of the enzyme . And the 29th tryptophan (Trp) was mutated to isoleucine (Ile) to maintain the stability of the molecular structure;

具有高活性的皮蝇胶原酶突变体序列如下: The sequence of the mutant collagenase with high activity is as follows:

Val Ile CysGlyGlySerLeuIleAspAsnLysTrpIleLeuThrAlaAlaHisCysValHisAspAlaValSerValValValTyrLeuGlySerAlaValGlnTyrGluGlyGluAlaValValAsnSerGluArgIleIleSerHisSerMetPheAsnProAspThrTyrLeuAsnAspValAlaLeuIleLysIleProHisValGluTyrThrAspAsnIleGlnProIleArgLeuProSerGlyGluGluLeuAsnAsnLysPheGluAsnIleTrpAlaThrValSerGlyTrpGlyGlnSerAsnThrAspThrValIleLeuGlnTyrThrTyrAsnLeuValIleAspAsnAspArgCysAlaGlnGluTyrProProGlyIleIleValGluSerThrIleCysGlyAspThrSerAspGlyLysSerProCysPheGlyAspSerGlyGlyProPheValLeuSerAspLysAsnLeuLeuIleGlyValValSerPheValSerGlyAlaGlyCysGluSerGlyLysProValGlyPheSerArgValThrSerTyrMetAspTrpIleGlnGlnAsnThrGlyIleLysPheVal Ile

该序列的特点是只保留了成熟皮蝇胶原酶序列中的功能区域和底物结合区(28~230位氨基酸)并将29位的色氨酸点突变为亮氨酸,这种改变在理论上使功能区域更大范围地暴露,使之能够更好的和反应底物结合,从而提高酶的活性; The characteristic of this sequence is that only the functional region and substrate binding region (28~230 amino acids) in the mature skin fly collagenase sequence are retained and the tryptophan at position 29 is mutated into leucine. This change is theoretically On the one hand, the functional area is exposed in a wider range, so that it can better combine with the reaction substrate, thereby improving the activity of the enzyme;

同时,本发明采用毕赤酵母分泌表达系统,该系统产量高、生产成本低兼有真核表达系统翻译后修饰功能等优点,可以用于大量生产皮蝇胶原酶,降低生产成本; At the same time, the present invention adopts the secretory expression system of Pichia pastoris, which has the advantages of high yield, low production cost and post-translational modification function of the eukaryotic expression system, and can be used for mass production of collagenase of the fly, reducing production cost;

皮蝇胶原酶毕赤酵母重组菌株的构建方法为:将修饰突变的皮蝇胶原酶Hl Collagenase基因插入pGAPZα-A空载体的GAP启动子/α-factor信号肽下游位点,并删除载体上的Kex2位点Lys-Arg之后的Ste13位点Glu-Ala-Glu-Ala,构建成皮蝇胶原酶基因分泌型表达载体Hl Collagenase-m/ pGAPZα-A;利用电转化的方法将Collagenase-m/ pGAPZα-A载体转化毕赤酵母(Pichia pastoris)的菌株GS115,构建成分泌型表达皮蝇胶原酶突变体的毕赤酵母工程菌株--- Hl Collagenase-m/ pGAPZα-A/GS115;通过抗生素筛选、SDS-PAGE电泳分析及生物比活性测定,获得高表达高活性的皮蝇胶原酶突变体毕赤酵母重组菌株; The construction method of Pichia pichia pichia collagenase recombinant strain is as follows: insert the modified and mutated skin fly collagenase Hl Collagenase gene into the GAP promoter/α-factor signal peptide downstream site of the pGAPZα-A empty vector, and delete the The Ste13 site Glu-Ala-Glu-Ala after the Kex2 site Lys-Arg was constructed into the expression vector Hl Collagenase-m/ pGAPZα-A of the fly collagenase gene secretion; the Collagenase-m/ pGAPZα -A vector transformed Pichia pastoris ( Pichia pastoris ) strain GS115, and constructed Pichia pastoris engineering strain --- Hl Collagenase-m/ pGAPZα-A/GS115, which secretes and expresses a mutant of pichia collagenase; through antibiotic selection, SDS-PAGE electrophoresis analysis and biological specific activity determination, obtained a recombinant strain of pichia pichia pastoris with high expression and high activity of collagenase mutant;

上述的毕赤酵母重组菌株目标蛋白:皮蝇胶原酶突变体(Hl Collagenase-m)的表达量达到241毫克/升,比活性为1320国际单位/毫克;目标蛋白皮蝇胶原酶突变体比天然的皮蝇胶原酶比活性高5~6倍,且具有很高的稳定性; The target protein of the above-mentioned Pichia pastoris recombinant strain: the expression of Hl Collagenase-m mutant (Hl Collagenase-m) reached 241 mg/L, and the specific activity was 1320 IU/mg; The specific activity of skin fly collagenase is 5~6 times higher, and it has high stability;

皮蝇胶原酶突变体的纯化方法为:利用获得高表达高活性的皮蝇胶原酶突变体毕赤酵母重组菌株进行发酵,离心收集上清液,以氢氧化钠调节PH值,过阴离子交换层析柱,收集目标洗脱峰,得到纯度约70%的皮蝇胶原酶突变体粗品,透析除盐,超滤浓缩,过分子筛层析柱,收集目标蛋白,得到纯度大于95%的皮蝇胶原酶突变体蛋白。 The purification method of the skin fly collagenase mutant is as follows: use the highly expressed and high activity skin fly collagenase mutant Pichia pastoris recombinant strain to ferment, centrifuge to collect the supernatant, adjust the pH value with sodium hydroxide, and pass through an anion exchange layer Analyze the column, collect the target elution peak, and obtain the crude product of collagenase mutant with a purity of about 70%, dialyze to remove salt, concentrate by ultrafiltration, pass through a molecular sieve chromatography column, collect the target protein, and obtain collagenase with a purity of more than 95% Enzyme mutant protein.

【附图说明】 【Description of drawings】

附图为皮蝇胶原酶突变体(Hl Collagenase-m)表达载体构建图 The attached picture shows the construction of the expression vector of the skin fly collagenase mutant (Hl Collagenase-m)

Hl Collagenase-m/ pGAPZα-A表达载体分子大小为3.759kb。其中pGAPZα-A为3.147kb,Hl Collagenase-m为612bp(包含终止子密码);Hl Collagenase-m插入于载体pGAPZα-A第747与824bp(XbaI位点)之间; The molecular size of Hl Collagenase-m/ pGAPZα-A expression vector is 3.759kb. Among them, pGAPZα-A is 3.147kb, H1 Collagenase-m is 612bp (including the terminator code); H1 Collagenase-m is inserted between the 747th and 824bp (XbaI site) of the vector pGAPZα-A;

pGAPZα-A载体结构为: The structure of the pGAPZα-A vector is:

磷酸甘油酸脱氢酶基因(GAP)启动子区域:第1-483bp Phosphoglycerate dehydrogenase gene (GAP) promoter region: 1-483bp

磷酸甘油酸脱氢酶基因启动子引物位点:第455-476bp Phosphoglycerate dehydrogenase gene promoter primer site: 455-476bp

α-交配因子分泌信号肽序列:第493-759bp α-mating factor secretion signal peptide sequence: 493-759bp

α-交配因子分泌信号肽引物位点:第696-716bp α-mating factor secretion signal peptide primer site: 696-716bp

载体多克隆位点:第760-828bp Vector multiple cloning site: 760-828bp

Myc抗原决定簇包:第827-856bp Myc epitope package: bp 827-856bp

3’-乙醇氧化酶1基因引物位点:第974-994bp 3'-Alcohol oxidase 1 gene primer site: 974-994bp

乙醇氧化酶1转录终止区域:第593-1233bp Alcohol oxidase 1 transcription termination region: 593-1233 bp

转录延伸因子1启动子区域:第1234-1644bp Transcription elongation factor 1 promoter region: 1234-1644 bp

合成原核启动子:第1645-1712bp Synthetic prokaryotic promoter: bp 1645-1712

链霉菌zeocin抗性基因阅读框:第1713-2087bp Streptomyces zeocin resistance gene reading frame: 1713-2087bp

细胞色素合成酶1转录终止区域:第2088-2405bp Cytochrome synthase 1 transcription termination region: bp 2088-2405

大肠杆菌复制子1(来源于pUC载体):第2416-3089bp。 E. coli replicon 1 (derived from pUC vector): 2416-3089 bp.

【具体实施方式】 【Detailed ways】

下面结合实施例详细介绍本发明在皮蝇胶原酶突变体重组毕赤酵母工程菌株的构建和皮蝇胶原酶突变体纯化工艺中的具体应用; The specific application of the present invention in the construction of the pichia collagenase mutant recombinant Pichia pastoris engineering strain and the purification process of the pichia collagenase mutant is described in detail below in conjunction with the examples;

实施例1 Example 1

皮蝇胶原酶突变体(Hl Collagenase-m)毕赤酵母工程菌的构建 Construction of Hl Collagenase-m Pichia pastoris engineering strain

1、          根据皮蝇胶原酶突变体的氨基酸序列和酵母对密码子的偏好,设计皮蝇胶原酶突变体全核苷酸序列,并在序列两端引入相应的酶切位点XhoI和XbaI,由大连宝生物公司合成该序列; 1. According to the amino acid sequence of the skin fly collagenase mutant and the yeast's preference for codons, the full nucleotide sequence of the skin fly collagenase mutant was designed, and the corresponding restriction sites XhoI and XbaI were introduced at both ends of the sequence. The sequence was synthesized by Dalian Bao Biological Company;

2、          采用基因克隆技术将皮蝇胶原酶突变体基因经XhoI/XbaI双酶切后插入pGAPZα-A之GAP启动子/α-factor信号肽下游的XhoI/XbaI位点,构建成含α-factor信号肽的分泌型毕赤酵母表达载体;Hl Collagenase-m/ pGAPZα-A表达载体分子大小为3.759kb,其中pGAPZα-A为3.147kb,Hl Collagenase-m为612bp(包含终止子),皮蝇胶原酶突变体插入于载体pGAPZα-A第747bp与824bp(XbaI位点)之间,具体情况见附图; 2. Using gene cloning technology, the mutant gene of the collagenase of the fly was inserted into the XhoI/XbaI site downstream of the GAP promoter/α-factor signal peptide of pGAPZα-A after double digestion with XhoI/XbaI to construct a gene containing α-factor Secretory Pichia pastoris expression vector of signal peptide; Hl Collagenase-m/ pGAPZα-A expression vector molecular size is 3.759kb, of which pGAPZα-A is 3.147kb, Hl Collagenase-m is 612bp (including terminator), skin fly collagen The enzyme mutant is inserted between the 747bp and 824bp (XbaI site) of the vector pGAPZα-A, see the attached figure for details;

3、          通过电转化方法,将线性化的Hl Collagenase-m/ pGAPZα-A质粒转入毕赤酵母GS115感受态(购于Invitrogen公司)中,通过zeocin抗生素筛选获得阳性菌株,进一步用PCR和Southern blotting技术鉴定筛选出的阳性菌株,再用SDS-PAGE电泳方法和SDS-PAGE活性测定方法筛选高表达高活性的Hl Collagenase-m/ pGAPZα-A/GS115工程菌株; 3. Through the electroporation method, the linearized Hl Collagenase-m/ pGAPZα-A plasmid was transferred into Pichia pastoris GS115 competent (purchased from Invitrogen Company), and positive strains were obtained by screening with zeocin antibiotics, and further PCR and Southern blotting were used to obtain positive strains. The positive strains screened out by technical identification, and then the H1 Collagenase-m/pGAPZα-A/GS115 engineering strain with high expression and high activity was screened by SDS-PAGE electrophoresis method and SDS-PAGE activity assay method;

实施例2 Example 2

皮蝇胶原酶突变体的纯化方法 Purification method of collagenase mutant of skinfly

1、          从-80℃种子库中取出Hl Collagenase-m/ pGAPZα-A/GS115工程菌,接种平板,使菌株活化; 1. Take out the Hl Collagenase-m/ pGAPZα-A/GS115 engineering bacteria from the -80°C seed bank, and inoculate the plate to activate the strain;

2、          从平板中挑单菌落于200毫升YPD+zeocin100毫克/升培养基中,30℃,250转/分钟,培养48小时,此为一级种子液; 2. Pick a single colony from the plate and put it in 200ml YPD+zeocin100mg/L medium, 30℃, 250 rpm, and cultivate for 48 hours. This is the first-class seed solution;

3、          吸取100毫升的一级种子液接种于2升的YPD培养基中,30℃,250转/分钟,培养24小时,此为二级种子液; 3. Take 100 ml of the primary seed liquid and inoculate it in 2 liters of YPD medium, at 30°C, 250 rpm, and cultivate for 24 hours. This is the secondary seed liquid;

4、          将2升的二级种子液接种于含40升YPD培养基的发酵罐中,发酵72小时,离心收集发酵上清液,以1摩尔氢氧化钠溶液调节PH8.0-9.0,过DEAE SepharoseFF层析柱,收集0.3摩尔/升氯化钠溶液洗脱峰,透析过夜除盐,此时可得到纯度大约为70%左右的皮蝇胶原酶突变体蛋白粗品,超滤浓缩,过G25层析柱,收集目标蛋白峰,得到纯度大于95%的皮蝇胶原酶突变体蛋白原液,将原液冻干保存。  4. Inoculate 2 liters of secondary seed liquid into a fermenter containing 40 liters of YPD medium, ferment for 72 hours, collect the fermentation supernatant by centrifugation, adjust the pH to 8.0-9.0 with 1 mole of sodium hydroxide solution, and pass DEAE SepharoseFF chromatographic column, collect the elution peak of 0.3 mol/L sodium chloride solution, dialyze overnight to remove salt, at this time, the crude product of collagenase mutant protein of skin fly with a purity of about 70% can be obtained, concentrated by ultrafiltration, and passed through the G25 layer Analyze the column, collect the peak of the target protein, and obtain the stock solution of the collagenase mutant protein with a purity greater than 95%, and freeze-dry the stock solution for storage. the

<110> 海南华研生物科技有限公司 <110> Hainan Huayan Biotechnology Co., Ltd.

<120>高表达高比活皮蝇胶原酶突变体序列、毕赤酵母表达质粒的构建及菌株筛选和纯化方法 <120> Construction of Highly Expressed Collagenase Mutant Sequence and Pichia Pichia Expression Plasmid, Strain Screening and Purification

<160> 1 <160> 1

<170> PatentIn Version 2.1 <170> PatentIn Version 2.1

<210> 1 <210> 1

<211> 203 <211> 203

<212>氨基酸 <212> amino acid

<213> Hypoderma lineatum (early cattle grub) <213> Hypoderma lineatum (early cattle grub)

<220> <220>

<221> misc_difference <221> misc_difference

<400> 1 <400> 1

Val Ile Cys Gly Gly Ser Leu Ile Asp Asn Lys Trp Ile Leu Thr Ala Val Ile Cys Gly Gly Ser Leu Ile Asp Asn Lys Trp Ile Leu Thr Ala

 1            5               10              15 1 5 10 15

Ala His Cys Val His Asp Ala Val Ser Val Val Val Tyr Leu Gly Ser Ala His Cys Val His Asp Ala Val Ser Val Val Val Tyr Leu Gly Ser

           20               25              30 20 25 30

Ala Val Gln Tyr Glu Gly Glu Ala Val Val Asn Ser Glu Arg Ile Ile Ala Val Gln Tyr Glu Gly Glu Ala Val Val Asn Ser Glu Arg Ile Ile

       35               40               45 35 40 45

Ser His Ser Met Phe Asn Pro Asp Thr Tyr Leu Asn Asp Val Ala Leu Ser His Ser Met Phe Asn Pro Asp Thr Tyr Leu Asn Asp Val Ala Leu

   50                55               60 50 55 60

Ile Lys Ile Pro His Val Glu Tyr Thr Asp Asn Ile Gln Pro Ile Arg Ile Lys Ile Pro His Val Glu Tyr Thr Asp Asn Ile Gln Pro Ile Arg

65             70               75              80 65 70 75 80

Leu Pro Ser Gly Glu Glu Leu Asn Asn Lys Phe Glu Asn Ile Trp Ala Leu Pro Ser Gly Glu Glu Leu Asn Asn Lys Phe Glu Asn Ile Trp Ala

              85                90              95 85 90 95

Thr Val Ser Gly Trp Gly Gln Ser Asn Thr Asp Thr Val Ile Leu Gln Thr Val Ser Gly Trp Gly Gln Ser Asn Thr Asp Thr Val Ile Leu Gln

          100              105             110 100 105 110

Tyr Thr Tyr Asn Leu Val Ile Asp Asn Asp Arg Cys Ala Gln Glu Tyr Tyr Thr Tyr Asn Leu Val Ile Asp Asn Asp Arg Cys Ala Gln Glu Tyr

       115             120               125          115 120 125

Pro Pro Gly Ile Ile Val Glu Ser Thr Ile Cys Gly Asp Thr Ser Asp Pro Pro Gly Ile Ile Val Glu Ser Thr Ile Cys Gly Asp Thr Ser Asp

   130            135             140     130 135 140

Gly Lys Ser Pro Cys Phe Gly Asp Ser Gly Gly Pro Phe Val Leu Ser Gly Lys Ser Pro Cys Phe Gly Asp Ser Gly Gly Pro Phe Val Leu Ser

145              150              155              160 145 150 155 160

Asp Lys Asn Leu Leu Ile Gly Val Val Ser Phe Val Ser Gly Ala Gly Asp Lys Asn Leu Leu Ile Gly Val Val Ser Phe Val Ser Gly Ala Gly

              165              170             175 165 170 175

Cys Glu Ser Gly Lys Pro Val Gly Phe Ser Arg Val Thr Ser Tyr Met Cys Glu Ser Gly Lys Pro Val Gly Phe Ser Arg Val Thr Ser Tyr Met

          180              185              190 180 185 190

Asp Trp Ile Gln Gln Asn Thr Gly Ile Lys Phe Asp Trp Ile Gln Gln Asn Thr Gly Ile Lys Phe

       195              200      203 195 200 203

 the

  the

Claims (8)

1. a torsalo collagenase (Hl Collagenase) two mutants specifically has following sequence
Val Ile CysGlyGlySerLeuIleAspAsnLysTrpIleLeuThrAlaAlaHisCysValHisAspAlaValSerValValValTyrLeuGlySerAlaValGlnTyrGluGlyGluAlaValValAsnSerGluArgIleIleSerHisSerMetPheAsnProAspThrTyrLeuAsnAspValAlaLeuIleLysIleProHisValGluTyrThrAspAsnIleGlnProIleArgLeuProSerGlyGluGluLeuAsnAsnLysPheGluAsnIleTrpAlaThrValSerGlyTrpGlyGlnSerAsnThrAspThrValIleLeuGlnTyrThrTyrAsnLeuValIleAspAsnAspArgCysAlaGlnGluTyrProProGlyIleIleValGluSerThrIleCysGlyAspThrSerAspGlyLysSerProCysPheGlyAspSerGlyGlyProPheValLeuSerAspLysAsnLeuLeuIleGlyValValSerPheValSerGlyAlaGlyCysGluSerGlyLysProValGlyPheSerArgValThrSerTyrMetAspTrpIleGlnGlnAsnThrGlyIleLysPhe。
2. a torsalo collagenase two mutants expression vector is characterized in that having changed in the expression plasmid the described torsalo collagenase of claim 1 mutant gene.
3. torsalo collagenase two mutants expression vector according to claim 2 is characterized in that described expression plasmid pGAPZ α-A.
4. the structure of a torsalo collagenase two mutants expression vector is characterized in that the torsalo collagenase Hl Collagenase gene of modifying sudden change is inserted the GAP promotor/α-site, factor signal peptide downstream of pGAPZ α-A empty carrier, and deletes on the carrier Kex2After the Lys-Arg of site Ste13Site Glu-Ala-Glu-Ala is built into torsalo collagenase gene secreted expression carrier Hl Collagenase-m/ pGAPZ α-A.
5. a transformant is characterized in that the host bacterium is transformed by claim 2 or 3 described torsalo collagenase expression carriers.
6. transformant according to claim 5, it is characterized in that described host bacterium be pichia spp ( Pichia pastoris) bacterial strain GS115.
7. a method of producing torsalo collagenase two mutants is characterized in that cultivating claim 5 or 6 described transformants, collects its secretory product.
8. the purification process of a torsalo collagenase two mutants Pichia anomala expression product is characterized in that directly separation and purification torsalo collagenase two mutants from the fermented liquid of secretor type torsalo collagenase two mutants Pichi strain Hl Collagenase-m/ pGAPZ α-A/GS115: centrifugal collection supernatant, regulate pH value with sodium hydroxide; Cross the anion-exchange chromatography post; Collect the target elution peak, obtain the torsalo collagenase two mutants bullion of purity about 70%, the dialysis desalination; Ultrafiltration and concentration; Cross molecular sieve chromatography, collect target protein, obtain purity greater than 95% torsalo collagenase mutant protein.
CN 201210141391 2012-05-09 2012-05-09 High-expression high-specific-activity torsalo collagenase mutant sequence, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain Active CN102660524B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210141391 CN102660524B (en) 2012-05-09 2012-05-09 High-expression high-specific-activity torsalo collagenase mutant sequence, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210141391 CN102660524B (en) 2012-05-09 2012-05-09 High-expression high-specific-activity torsalo collagenase mutant sequence, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain

Publications (2)

Publication Number Publication Date
CN102660524A true CN102660524A (en) 2012-09-12
CN102660524B CN102660524B (en) 2013-02-20

Family

ID=46770104

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210141391 Active CN102660524B (en) 2012-05-09 2012-05-09 High-expression high-specific-activity torsalo collagenase mutant sequence, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain

Country Status (1)

Country Link
CN (1) CN102660524B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109837241A (en) * 2019-03-20 2019-06-04 济南赛尔生物科技股份有限公司 The separation of fat stem cell and cultural method
CN115011583A (en) * 2021-11-26 2022-09-06 河南合智医药科技有限公司 High-expression high-specific-activity proteinase K mutant sequence, construction of pichia pastoris expression plasmid, and strain screening and purifying method
CN115369103A (en) * 2021-11-26 2022-11-22 河南合智医药科技有限公司 Construction of high specific activity keratinase mutant and pichia pastoris expression plasmid, and strain screening and purifying method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1664097A (en) * 2004-10-29 2005-09-07 中国农业科学院上海家畜寄生虫病研究所 Expression of Hypoderm A (HA) in pastoris system and use thereof
CN101294184A (en) * 2007-04-25 2008-10-29 中国农业科学院上海兽医研究所 A method of producing dermatocin C using Pichia pastoris

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1664097A (en) * 2004-10-29 2005-09-07 中国农业科学院上海家畜寄生虫病研究所 Expression of Hypoderm A (HA) in pastoris system and use thereof
CN101294184A (en) * 2007-04-25 2008-10-29 中国农业科学院上海兽医研究所 A method of producing dermatocin C using Pichia pastoris

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANNE LECROISEY: "Chemical and Enzymatic Characterization of the Collagenase from the Insect Hypoderma lineaturn", 《EUR. J. BIOCHEM.》 *
CHANTAL BOULARD: "characterization of a collagenolytic enzyme from larvae of hypoderma lineatum", 《COMP.BIOCHEM.PHYSIOL.》 *
ISABELLE BROUTIN: "1.8 ~ Structure of Hypoderma lineatum Collagenase: a Member of the Serine Proteinase Family", 《ACTA CRYST.》 *
ROSA CASAIS: "Hypoderma lineatum: expression of enzymatically active hyrpdermin C in Escherichia coli and its use for the immunodiagnosis of hypodermosis", 《EXPERIMENTAL PARASITOLOGY》 *
高兴春,徐梅倩,何国声: "皮蝇素! 蛋白在毕赤酵母中的表达及纯化", 《生物工程学报》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109837241A (en) * 2019-03-20 2019-06-04 济南赛尔生物科技股份有限公司 The separation of fat stem cell and cultural method
CN109837241B (en) * 2019-03-20 2022-05-17 济南赛尔生物科技股份有限公司 Method for separating and culturing adipose-derived stem cells
CN115011583A (en) * 2021-11-26 2022-09-06 河南合智医药科技有限公司 High-expression high-specific-activity proteinase K mutant sequence, construction of pichia pastoris expression plasmid, and strain screening and purifying method
CN115369103A (en) * 2021-11-26 2022-11-22 河南合智医药科技有限公司 Construction of high specific activity keratinase mutant and pichia pastoris expression plasmid, and strain screening and purifying method

Also Published As

Publication number Publication date
CN102660524B (en) 2013-02-20

Similar Documents

Publication Publication Date Title
US8114632B2 (en) Method of producing biologically active polypeptide having insulinotropic activity
CN100587073C (en) Recombinant Expression of Human Fibroblast Growth Factor-21
WO2020182229A1 (en) Fusion protein and method of preparing liraglutide intermediate polypeptide thereof
CN116286900B (en) Acetate permease A gene RkAcpa and its application
CN110343688A (en) Alkali protease PA3 and its encoding gene and application
CN110724187B (en) Recombinant engineering bacterium for efficiently expressing liraglutide precursor and application thereof
CN111320702A (en) Method for efficient secretion fusion expression and recombinant preparation of bacillus prodigiosus nuclease in methanol yeast
CN102660524B (en) High-expression high-specific-activity torsalo collagenase mutant sequence, construction of Pichia pastoris expression plasmid, and methods for screening and purifying strain
CN114761553A (en) Nucleic acids, vectors, host cells and methods for producing beta-fructofuranosidase from aspergillus niger
CN116554309A (en) Recombinant human III type collagen and preparation method and application thereof
CN116970067A (en) A strategy to improve the recombinant expression level of human serum albumin
EP1313848B1 (en) Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
CN102994601A (en) Method for preparing collagen small peptide by utilizing marine collagenase MCP-01
CN116042502A (en) Genetically engineered bacterium capable of secreting mussel protein extracellularly, construction method and application thereof
CN114634920B (en) Recombinant pichia pastoris for producing human hyaluronidase PH20 and construction method thereof
CN101665798B (en) Method for preparing recombinant human serum albumin and interferon alpha fusion protein
CN102925451A (en) Gene recombinant human growth hormone preparation method
AU2019218315A1 (en) Codon optimized precursor gene and signal peptide gene of human insulin analogue
CN101538318B (en) A kind of signal peptide and its coding gene and application
CN103031290B (en) High-sugar-tolerant beta-glucosaccharase Bg14, and expressed gene and application thereof
CN110846294B (en) Recombinant pectinase and its gene, recombinant vector, preparation method and application
CN101280017A (en) Fused protein of human brain natriuretic peptide diad [(BNP)2] and human serum albumin (HAS), and preparation thereof
CN117903319A (en) A human lactoferrin peptide trimer fusion protein and its preparation method and application
CN118085023A (en) Preparation method of short peptide
CN110592045A (en) A kind of recombinant esterase, gene, engineering bacteria and application of splitting (R,S)-indoline-2-ethyl carboxylate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address

Address after: 570100 No.12, Meifeng Road, Meian science and technology new town, national high tech Zone, Haikou City, Hainan Province

Patentee after: Hainan Huayan Collagen Technology Co.,Ltd.

Address before: 570102 15th floor, qiaohui building, 21 Yilong West Road, Longhua District, Haikou City, Hainan Province

Patentee before: HAINAN HUAYAN BIOTECH Co.,Ltd.

CP03 Change of name, title or address
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Construction of Pichia pastoris expression plasmid with high expression of collagenase mutants and screening and purification of strains

Effective date of registration: 20210331

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2021980002334

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20220406

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2021980002334

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Construction of collagenase mutant sequence with high expression and high specific activity of Pichia pastoris, strain screening and purification method

Effective date of registration: 20220408

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2022460000001

PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20230330

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2022460000001

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Construction of Pichia pastoris expression plasmid and strain screening and purification method for high expression and high specific activity skin fly collagenase mutant sequence

Effective date of registration: 20230407

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2023980037450

PC01 Cancellation of the registration of the contract for pledge of patent right

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2023980037450

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Construction of high expression and high specific activity skin fly collagenase mutant sequence, Pichia pastoris expression plasmid, and strain screening and purification methods

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2024980013441

PE01 Entry into force of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2024980013441

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Construction of Pichia pastoris expression plasmid with high expression of collagenase mutants and screening and purification of strains

Granted publication date: 20130220

Pledgee: Agricultural Bank of China Limited Haikou Longhua sub branch

Pledgor: Hainan Huayan Collagen Technology Co.,Ltd.

Registration number: Y2025980022672